Commission "Virus Disinfection" issues statement on the new coronavirus SARS-CoV-2

Freiburg/Berlin, März 2020 – Die gemeinsame Kommission „Virusdesinfektion“ der Gesellschaft für Virologie (GfV) und der Deutschen Vereinigung zur Bekämpfung von Viruskrankheiten (DVV) hat eine Stellungnahme zum Einsatz von Desinfektionsmitteln bei Infektionsverdacht oder bei nachgewiesener Infektion mit dem neuartigen Coronavirus SARS-CoV-2 erarbeitet. Die Publikation ist ab sofort auf der Website der GfV einsehbar.

As there is currently neither a vaccine nor medication available to prevent or treat the novel coronavirus SARS-CoV-2, comprehensive hygiene measures are currently of particular importance.

In clinics and practices, hand and surface disinfection is a central part of these measures. The statement summarises which disinfectants are suitable for inactivating the novel coronavirus SARS-CoV-2: All disinfectants with proven limited virucidal efficacy are effective. Products with the limited virucidal PLUS and virucidal spectrum of activity can also be used. Suitable products can be found in the lists of the Association for Applied Hygiene (VAH) and the Robert Koch Institute (RKI). As there may currently be supply bottlenecks for disinfectants, alcoholic solutions produced in pharmacies according to the standard approval 2 propanol 70% (v/v) or the ethanol-based WHO formulation I or 2 propanol-containing WHO formulation II can alternatively be used for hand disinfection.

The use of disinfectants is only necessary and sensible in medical facilities and - after consultation with the doctor or the public health department - in the domestic environment of proven infected persons. The authors of the statement once again point out that for healthy people, regular and thorough hand washing with soap for at least 20 seconds is the most important measure to protect against infection with the novel coronavirus SARS-CoV-2.

The current statement was prepared under the leadership of PD Dr Maren Eggers, Chair of the GFV/DVV Commission on Virus Disinfection.

Die vollständige Stellungnahme ist abrufbar unter: https://www.g-f-v.org/stellungnahmen_detail

Abdruck erwünscht – Beleg erbeten.
Kontakt für Journalisten:

GfV Pressestelle
Juliane Pfeiffer
Postfach 30 11 20
70451 Stuttgart
Tel.: 0711 8931-693
Fax: 0711 8931-167
pfeiffer@medizinkommunikation.org
www.g-f-v.org

DGfI Geschäftsstelle
c/o DRFZ, Virchowweg 12
10117 Berlin
Tel.: 030 28460 648
mail@dgfi.org